Real-world evidence on the effectiveness and safety of gliclazide MR 60 mg in Bangladeshi patients with Type II diabetes during fasting: a sub-analysis from the global DIA-RAMADAN study

• Published in: Journal of comparative effectiveness research Vol. 13; no. 2; p. e230132
• Main Authors: Uddin, Mohammed Farid, Khan, Murshed Ahamed, Selim, Shahjada, Sultana, Nusrat, Sayem, Mohammad Abu, Iftekhar, Mohammed Mahboob, Habib, Maruf Bin, Akter, Nazma, Khan, Shahjamal
• Format: Journal Article
• Language: English
• Published: England Becaris Publishing Ltd 01.02.2024; Becaris Publishing Limited
• Subjects: diabetes; fasting; gliclazide modified release; hypoglycemia; ramadan; gliclazide modified release; fasting; Ramadan; diabetes; hypoglycemia

Many Muslims with Type II diabetes (T2DM) fast during Ramadan, which can put them at increased risk of hypoglycemia. This sub-analysis of the global DIA-RAMADAN study assessed the effectiveness and safety of gliclazide modified release (MR) 60 mg in the Bangladeshi cohort. DIA-RAMADAN was an interna...